Free Trial

Soligenix (SNGX) Competitors

Soligenix logo
$1.75 +0.10 (+5.82%)
As of 01:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SNGX vs. DARE, ENLV, CVKD, PASG, LPTX, PMN, LNAI, CASI, MIRA, and TAOX

Should you be buying Soligenix stock or one of its competitors? The main competitors of Soligenix include Dare Bioscience (DARE), Enlivex Therapeutics (ENLV), Cadrenal Therapeutics (CVKD), Passage Bio (PASG), Leap Therapeutics (LPTX), Promis Neurosciences (PMN), Lunai Bioworks (LNAI), CASI Pharmaceuticals (CASI), MIRA Pharmaceuticals (MIRA), and Synaptogenix (TAOX). These companies are all part of the "pharmaceutical products" industry.

Soligenix vs. Its Competitors

Dare Bioscience (NASDAQ:DARE) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Dare Bioscience has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Soligenix has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500.

Dare Bioscience presently has a consensus target price of $10.00, indicating a potential upside of 389.00%. Soligenix has a consensus target price of $6.00, indicating a potential upside of 243.64%. Given Dare Bioscience's stronger consensus rating and higher probable upside, equities analysts plainly believe Dare Bioscience is more favorable than Soligenix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dare Bioscience
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Soligenix
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

6.7% of Dare Bioscience shares are held by institutional investors. Comparatively, 3.6% of Soligenix shares are held by institutional investors. 4.8% of Dare Bioscience shares are held by company insiders. Comparatively, 3.1% of Soligenix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Soligenix had 1 more articles in the media than Dare Bioscience. MarketBeat recorded 1 mentions for Soligenix and 0 mentions for Dare Bioscience. Dare Bioscience's average media sentiment score of 1.73 beat Soligenix's score of 0.00 indicating that Dare Bioscience is being referred to more favorably in the media.

Company Overall Sentiment
Dare Bioscience Very Positive
Soligenix Neutral

Dare Bioscience's return on equity of 0.00% beat Soligenix's return on equity.

Company Net Margins Return on Equity Return on Assets
Dare BioscienceN/A N/A -103.70%
Soligenix N/A -274.76%-129.20%

Dare Bioscience has higher earnings, but lower revenue than Soligenix. Dare Bioscience is trading at a lower price-to-earnings ratio than Soligenix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dare Bioscience$10K2,756.66-$4.05M-$2.14-0.96
Soligenix$120K62.42-$8.27M-$3.80-0.46

Summary

Dare Bioscience beats Soligenix on 11 of the 15 factors compared between the two stocks.

Get Soligenix News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNGX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNGX vs. The Competition

MetricSoligenixMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7.53M$3.47B$6.17B$10.68B
Dividend YieldN/A2.27%5.72%4.83%
P/E Ratio-0.4623.4029.4727.34
Price / Sales62.42479.21587.77132.79
Price / CashN/A45.2825.8230.35
Price / Book1.0610.5212.446.68
Net Income-$8.27M-$52.71M$3.32B$276.46M
7 Day Performance1.51%4.72%2.15%0.77%
1 Month Performance-35.09%15.59%8.41%3.73%
1 Year Performance-54.83%13.83%61.67%36.59%

Soligenix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNGX
Soligenix
2.44 of 5 stars
$1.75
+5.8%
$6.00
+243.6%
-57.3%$7.53M$120K-0.4620
DARE
Dare Bioscience
2.536 of 5 stars
$2.12
flat
$10.00
+371.7%
-45.6%$28.58M$10K-0.9930Positive News
ENLV
Enlivex Therapeutics
2.6969 of 5 stars
$1.10
-4.3%
$10.00
+809.1%
-30.3%$27.94MN/A-1.9070Gap Up
CVKD
Cadrenal Therapeutics
2.9095 of 5 stars
$13.99
+2.7%
$32.00
+128.7%
-21.0%$27.88MN/A-1.584
PASG
Passage Bio
3.0727 of 5 stars
$8.69
+2.6%
$75.67
+770.7%
-30.4%$26.93MN/A-0.48130News Coverage
LPTX
Leap Therapeutics
2.8214 of 5 stars
$0.60
-5.5%
$3.38
+459.6%
-79.4%$26.46MN/A-0.3840News Coverage
Positive News
Analyst Downgrade
Short Interest ↓
Gap Up
PMN
Promis Neurosciences
3.6175 of 5 stars
$0.48
-2.0%
$4.33
+802.8%
-55.8%$26.37MN/A-2.295Positive News
Short Interest ↓
LNAI
Lunai Bioworks
N/A$1.16
+2.7%
N/AN/A$26.19MN/A-0.1520Gap Up
CASI
CASI Pharmaceuticals
3.5751 of 5 stars
$1.89
-4.5%
$4.00
+111.6%
-68.8%$24.35M$28.54M-0.65180
MIRA
MIRA Pharmaceuticals
0.3774 of 5 stars
$1.29
+2.0%
N/A+47.3%$24.03MN/A-2.622Gap Down
TAOX
Synaptogenix
0.0678 of 5 stars
$9.54
+38.5%
N/AN/A$24.03MN/A-0.474News Coverage
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SNGX) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners